Apollon Wealth Management, LLC Clearside Biomedical, Inc. Transaction History
Apollon Wealth Management, LLC
- $5.29 Billion
- Q3 2025
A detailed history of Apollon Wealth Management, LLC transactions in Clearside Biomedical, Inc. stock. As of the latest transaction made, Apollon Wealth Management, LLC holds 11,793 shares of CLSD stock, worth $46,582. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,793Holding current value
$46,582% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CLSD
# of Institutions
44Shares Held
11.6MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA3.36MShares$13.3 Million0.0% of portfolio
-
Act Capital Management, LLC Wayne, PA2.2MShares$8.68 Million3.43% of portfolio
-
Carmignac Gestion Paris, I01.51MShares$5.96 Million0.02% of portfolio
-
Black Rock Inc. New York, NY798KShares$3.15 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA790KShares$3.12 Million0.0% of portfolio
About Clearside Biomedical, Inc.
- Ticker CLSD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,190,700
- Market Cap $238M
- Description
- Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injec...